WeedMD Inc. and CannTx Life Sciences Sign Definitive Acquisition Agreement and Confirm Corporate Name as Entourage Health Corp.
On closing, merged company to combine innovative medical business, low-cost cultivation, specialized craft cannabis, micropropagation, and solventless...
WeedMD Inc. Announces Intent to Change Corporate Name to Entourage Health Corp.
Company reports results of Annual General & Special Meeting of Shareholders held on June 30, 2021 which includes overwhelming shareholder approval...
WeedMD Reports First Quarter 2021 Financial Results with 102% Record Increase in Sequential Net Revenue Growth
WeedMD announced today its financial results for the three months ended March 31, 2021.
WeedMD Expands its Color Cannabis Brand into the Province of New Brunswick
Award-winning adult-use brand Color now available coast-to-coast in 90% of Canada’s retail markets
WeedMD Sells Fully Licensed Bowmanville Operating Assets
Closes share-sale transaction with Final Bell Canada Inc. following Starseed Medicinal’s full production and product fulfillment move to Company’s consolidated London-area facilities...
WeedMD and Privately Owned CannTx Life Sciences Sign Letter of Intent to Create a Cannabis Cultivation and Consumer-Centric Product Portfolio
WeedMD is pleased to announce it has signed a Letter of Intent to acquire all of the issued and outstanding shares of renowned craft cultivator CannTx Life Sciences Inc...
WeedMD Reports Fiscal Year 2020 Financial Results and First Quarter 2021 Preliminary Gross Revenue of $12 Million
WeedMD announced today its financial results for the fiscal year ended December 31, 2020.
WeedMD to Host Fiscal Year End 2020 Conference Call on May 31st
Company financials to be filed after market on May 28, 2021 and operational outlook to be provided during call, including first quarter 2021 record milestones achieved
WeedMD Launches New Product Collaboration with CannTx Life Sciences for Release of Limited Edition Cultivars to Starseed Medicinal
Company expands into premium craft offering with exclusive licensing for ‘Limited Edition’ high-THC craft strains Rockstar Tuna and Royal Goddess for Starseed patients...
WeedMD Inc. Provides Bi-Weekly Status Report Regarding Management Cease Trade Order and Update Regarding Interim Financial Statements
WeedMD is providing a bi-weekly update on the status of the management cease trade order granted on May 3, 2021 (the "MCTO") by its principal regulator...
WeedMD Management to Present at Canaccord Genuity’s Annual Global Cannabis Virtual Conference on May 11th
WeedMD is pleased to announce that George Scorsis, WeedMD’s CEO and Executive Chairman, and the Company’s newly appointed CFO Beth Carreon are scheduled...
WeedMD Inc. Granted Management Cease Trade Order
WeedMD confirmed today that further to its news release dated April 21, 2021, the Company's principal regulator, the Ontario Securities Commission...
WeedMD Announces Delayed Filing of its 2020 Annual Financial Disclosure
WeedMD announced today that the filing of its audited annual financial statements, management's discussion and analysis, and related CEO...
WeedMD Announces Participation in Upcoming Investor Events
WeedMD is pleased to announce that George Scorsis, WeedMD’s CEO and Executive Chair, is scheduled to participate in the following upcoming investor events...
WeedMD Appoints Dynamic Leader Beth Carreon as New Chief Financial Officer
Formerly of Tilray Canada and Nestlé Canada, brings over 20 years of corporate finance, banking, M&A, and CPG experience
WeedMD Added to Horizons Marijuana Life Sciences Index ETF
WeedMD is pleased to announce the Company has been added to the Horizons Marijuana Life Sciences Index ETF following HMMJ’s quarterly rebalancing...
WeedMD Announces Supplemental Listing of Warrants
WeedMD announced today that the TSX Venture Exchange has accepted for listing 19,046,875 common share purchase warrants of the Company issued in...
WeedMD’s Color Cannabis Expands Product Portfolio with Debut of Live Resin in Pedro’s Sweet Sativa Cultivar
Company partners with Ontario’s Peak Processing to produce high-margin specialty products using terpene-rich biomass, with live resin available for sale in Ontario commencing in May, 2021
WeedMD Announces Closing of $17.25 Million Bought Deal Offering
WeedMD s pleased to confirm it has closed its previously announced bought deal short-form prospectus offering of 35,937,500 units (“Units”) at a price...
WeedMD Inc. Announces Amendment of Bought Deal Equity Financing
WeedMD announced today that, further to its press release dated February 11, 2021 announcing a $17.5 million bought deal financing, the Company has...